PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 93 filers reported holding PLIANT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,862,728 | +55.1% | 2,933,260 | +62.0% | 4.83% | +87.9% |
| Q2 2023 | $32,800,389 | -13.5% | 1,810,176 | +27.0% | 2.57% | -24.7% |
| Q1 2023 | $37,914,416 | +85.4% | 1,425,354 | +34.7% | 3.41% | +79.9% |
| Q4 2022 | $20,448,840 | +1.4% | 1,057,881 | +9.6% | 1.90% | -7.0% |
| Q3 2022 | $20,161,000 | +227.1% | 965,114 | +25.4% | 2.04% | +184.5% |
| Q2 2022 | $6,163,000 | +113.8% | 769,370 | +87.0% | 0.72% | +182.3% |
| Q1 2022 | $2,883,000 | -44.8% | 411,328 | +6.3% | 0.25% | -32.1% |
| Q4 2021 | $5,223,000 | – | 386,896 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |